We have received the following update to the supply of SINEMET CR® (levodopa/carbidopa) 200 mg/50 mg controlled release tablets.
The long-standing shortage of a formulation of Levodopa/Carbidopa 200/50 (Sinemet CR) has been resolved.
The manufacturers, MSD (Merck, Sharp & Dohme) Australia, have announced that this medication is once again available. The only change is that Sinemet CR will now be packed in a bottle containing 100 tablets as opposed to the previous packaging in a blister pack containing 60 tablets.
Naturally any queries about prescribing of this medication should be directed to your treating medical specialist.
See attached PDF.
For more background see earlier news item.